PROGRAM


9:30 - 9:40

開会あいさつ、諸注意


9:40 - 10:30

【基調講演】AAVの品質評価戦略
In-vivo GT Control Strategy: Need for Adequate (Pre-) cQAs and for cognate analytical technologies of AAV Based GT Products
Roland Pach Global Expert Cell and Gene Therapy Analytics, F.Hoffmann-La Roche Ltd
MORE INFO


10:35 - 11:15

【グローバルトレンド&トピック】Biacore & AKTA
Current PAT trends, Regulatory Update and Novel Quality Control Assays
Fredrik Sundberg Global Director Strategic Technology Partnerships, Cytiva
MORE INFO


11:20 - 12:00

【ケーススタディ】Biacore & AKTA
Experimental evidence for enhanced receptor binding by rapidly spreading SARS-CoV-2 variants.
Joyce H. G. Lebbink Associate Professor at Dept. of Molecular Genetics, Erasmus University Medical Center
MORE INFO


13:00 - 13:40

【ケーススタディ】Biacore
Calibration-Free Concentration Analysis for Quantification of Anti-Drug Specific Antibodies in Positive Control Antibodies and in Clinical Samples
Christina Aniol-Nielsen, Henrik Toft-Hansen Clinical Immunogenicity Analysis, Novo Nordisk
MORE INFO


13:45 - 14:25

【グローバルトレンド&トピック】HCP
Challenges of host cell protein analysis, from technical to logistics
Joe Hirano Program manager, Imaging and Western Blotting, Cytiva
MORE INFO


14:30 - 15:10

【ケーススタディ】Biacore
Innovative antibody therapeutics and SPR
Chifumi Teramoto (Seida) Chugai Pharmaceutical Co., Ltd.Discovery Biologics Dept. Protein Analysis Group,Research Div.
MORE INFO


15:15 - 15:55

【ケーススタディ】AAVなど分析
Analytics in viral vector bioprocessing
Åsa Hagner McWhirter Senior Scientist, Cytiva
MORE INFO


16:00 - 16:40

【ケーススタディ】Biacore
How to identify aggregate selective antibodies using SPR
Patrik Nygren Senior Scientist, BioArctic
MORE INFO


16:45 - 18:15

オンライン懇親会、ポスター発表(各ご講演間にご参加・ご利用方法スライド放映)